Annual Total Long Term Liabilities
$2.74 M
-$3.20 M-53.86%
31 December 2023
Summary:
Repare Therapeutics annual total long term liabilities is currently $2.74 million, with the most recent change of -$3.20 million (-53.86%) on 31 December 2023. During the last 3 years, it has fallen by -$56.50 million (-95.37%). RPTX annual total long term liabilities is now -98.10% below its all-time high of $144.58 million, reached on 31 December 2019.RPTX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$346.00 K
+$128.00 K+58.72%
30 September 2024
Summary:
Repare Therapeutics quarterly total long term liabilities is currently $346.00 thousand, with the most recent change of +$128.00 thousand (+58.72%) on 30 September 2024. Over the past year, it has dropped by -$3.72 million (-91.49%). RPTX quarterly long term liabilities is now -99.76% below its all-time high of $144.58 million, reached on 31 December 2019.RPTX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RPTX Long Term Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -53.9% | -91.5% |
3 y3 years | -95.4% | -99.4% |
5 y5 years | -92.0% | - |
RPTX Long Term Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -95.4% | at low | -99.4% | +58.7% |
5 y | 5 years | -98.1% | at low | -99.8% | +58.7% |
alltime | all time | -98.1% | at low | -99.8% | +58.7% |
Repare Therapeutics Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $346.00 K(+58.7%) |
June 2024 | - | $218.00 K(-61.1%) |
Mar 2024 | - | $561.00 K(-79.5%) |
Dec 2023 | $2.74 M(-53.9%) | $2.74 M(-32.6%) |
Sept 2023 | - | $4.07 M(+39.2%) |
June 2023 | - | $2.92 M(-29.2%) |
Mar 2023 | - | $4.13 M(-30.5%) |
Dec 2022 | $5.94 M | $5.94 M(-85.7%) |
Sept 2022 | - | $41.51 M(-3.7%) |
June 2022 | - | $43.09 M(-3.0%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $44.41 M(-1.8%) |
Dec 2021 | $45.20 M(-23.7%) | $45.20 M(-16.3%) |
Sept 2021 | - | $53.98 M(+3.1%) |
June 2021 | - | $52.34 M(-11.3%) |
Mar 2021 | - | $58.99 M(-0.4%) |
Dec 2020 | $59.24 M(-59.0%) | $59.24 M(-0.0%) |
Sept 2020 | - | $59.25 M(+1.7%) |
June 2020 | - | $58.28 M(-59.6%) |
Mar 2020 | - | $144.40 M(-0.1%) |
Dec 2019 | $144.58 M(+320.2%) | $144.58 M |
Dec 2018 | $34.40 M | - |
FAQ
- What is Repare Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Repare Therapeutics?
- What is Repare Therapeutics annual total long term liabilities year-on-year change?
- What is Repare Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Repare Therapeutics?
- What is Repare Therapeutics quarterly long term liabilities year-on-year change?
What is Repare Therapeutics annual total long term liabilities?
The current annual total long term liabilities of RPTX is $2.74 M
What is the all time high annual total long term liabilities for Repare Therapeutics?
Repare Therapeutics all-time high annual total long term liabilities is $144.58 M
What is Repare Therapeutics annual total long term liabilities year-on-year change?
Over the past year, RPTX annual total long term liabilities has changed by -$3.20 M (-53.86%)
What is Repare Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of RPTX is $346.00 K
What is the all time high quarterly long term liabilities for Repare Therapeutics?
Repare Therapeutics all-time high quarterly total long term liabilities is $144.58 M
What is Repare Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, RPTX quarterly total long term liabilities has changed by -$3.72 M (-91.49%)